81 related articles for article (PubMed ID: 15743665)
1. DeltaNp53 or p44: priming the p53 pump.
Scrable H; Sasaki T; Maier B
Int J Biochem Cell Biol; 2005 May; 37(5):913-9. PubMed ID: 15743665
[TBL] [Abstract][Full Text] [Related]
2. Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues.
Muttray AF; Cox RL; Reinisch CL; Baldwin SA
Mar Biotechnol (NY); 2007; 9(2):217-30. PubMed ID: 17242983
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of p53 function by the N-terminal ΔNp53 and Δ113p53 isoforms in zebrafish embryos.
Davidson WR; Kari C; Ren Q; Daroczi B; Dicker AP; Rodeck U
BMC Dev Biol; 2010 Oct; 10():102. PubMed ID: 20929554
[TBL] [Abstract][Full Text] [Related]
4. The amyloid precursor protein (APP) intracellular domain regulates translation of p44, a short isoform of p53, through an IRES-dependent mechanism.
Li M; Pehar M; Liu Y; Bhattacharyya A; Zhang SC; O'Riordan KJ; Burger C; D'Adamio L; Puglielli L
Neurobiol Aging; 2015 Oct; 36(10):2725-36. PubMed ID: 26174856
[TBL] [Abstract][Full Text] [Related]
5. The human ΔNp53 isoform triggers metabolic and gene expression changes that activate mTOR and alter mitochondrial function.
Lin SC; Karoly ED; Taatjes DJ
Aging Cell; 2013 Oct; 12(5):863-72. PubMed ID: 23734707
[TBL] [Abstract][Full Text] [Related]
6. Cellular and organismal ageing: Role of the p53 tumor suppressor protein in the induction of transient and terminal senescence.
Schmid G; Kramer MP; Maurer M; Wandl S; Wesierska-Gadek J
J Cell Biochem; 2007 Aug; 101(6):1355-69. PubMed ID: 17471501
[TBL] [Abstract][Full Text] [Related]
7. Modulation of mammalian life span by the short isoform of p53.
Maier B; Gluba W; Bernier B; Turner T; Mohammad K; Guise T; Sutherland A; Thorner M; Scrable H
Genes Dev; 2004 Feb; 18(3):306-19. PubMed ID: 14871929
[TBL] [Abstract][Full Text] [Related]
8. Altered longevity-assurance activity of p53:p44 in the mouse causes memory loss, neurodegeneration and premature death.
Pehar M; O'Riordan KJ; Burns-Cusato M; Andrzejewski ME; del Alcazar CG; Burger C; Scrable H; Puglielli L
Aging Cell; 2010 Apr; 9(2):174-90. PubMed ID: 20409077
[TBL] [Abstract][Full Text] [Related]
9. Role of the newer p53 family proteins in malignancy.
Irwin MS; Kaelin WG
Apoptosis; 2001; 6(1-2):17-29. PubMed ID: 11321038
[TBL] [Abstract][Full Text] [Related]
10. DeltaN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53.
Courtois S; Verhaegh G; North S; Luciani MG; Lassus P; Hibner U; Oren M; Hainaut P
Oncogene; 2002 Oct; 21(44):6722-8. PubMed ID: 12360399
[TBL] [Abstract][Full Text] [Related]
11. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.
Yang A; Kaghad M; Wang Y; Gillett E; Fleming MD; Dötsch V; Andrews NC; Caput D; McKeon F
Mol Cell; 1998 Sep; 2(3):305-16. PubMed ID: 9774969
[TBL] [Abstract][Full Text] [Related]
12. p53 isoforms can regulate p53 transcriptional activity.
Bourdon JC; Fernandes K; Murray-Zmijewski F; Liu G; Diot A; Xirodimas DP; Saville MK; Lane DP
Genes Dev; 2005 Sep; 19(18):2122-37. PubMed ID: 16131611
[TBL] [Abstract][Full Text] [Related]
13. High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?
Crook T; Nicholls JM; Brooks L; O'Nions J; Allday MJ
Oncogene; 2000 Jul; 19(30):3439-44. PubMed ID: 10918601
[TBL] [Abstract][Full Text] [Related]
14. G-quadruplex structures in TP53 intron 3: role in alternative splicing and in production of p53 mRNA isoforms.
Marcel V; Tran PL; Sagne C; Martel-Planche G; Vaslin L; Teulade-Fichou MP; Hall J; Mergny JL; Hainaut P; Van Dyck E
Carcinogenesis; 2011 Mar; 32(3):271-8. PubMed ID: 21112961
[TBL] [Abstract][Full Text] [Related]
15. Regulation of human p53 activity and cell localization by alternative splicing.
Ghosh A; Stewart D; Matlashewski G
Mol Cell Biol; 2004 Sep; 24(18):7987-97. PubMed ID: 15340061
[TBL] [Abstract][Full Text] [Related]
16. IRES mediated translational regulation of p53 isoforms.
Sharathchandra A; Katoch A; Das S
Wiley Interdiscip Rev RNA; 2014; 5(1):131-9. PubMed ID: 24343861
[TBL] [Abstract][Full Text] [Related]
17. Loss of transactivation and transrepression function, and not RPA binding, alters growth suppression by p53.
Leiter LM; Chen J; Marathe T; Tanaka M; Dutta A
Oncogene; 1996 Jun; 12(12):2661-8. PubMed ID: 8700525
[TBL] [Abstract][Full Text] [Related]
18. p53 protein variants: structural and functional similarities with p63 and p73 isoforms.
Courtois S; Caron de Fromentel C; Hainaut P
Oncogene; 2004 Jan; 23(3):631-8. PubMed ID: 14737098
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization and expression of p63 isoforms in human keloids.
De Felice B; Wilson RR; Nacca M; Ciarmiello LF; Pinelli C
Mol Genet Genomics; 2004 Aug; 272(1):28-34. PubMed ID: 15248062
[TBL] [Abstract][Full Text] [Related]
20. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family.
Flores ER; Sengupta S; Miller JB; Newman JJ; Bronson R; Crowley D; Yang A; McKeon F; Jacks T
Cancer Cell; 2005 Apr; 7(4):363-73. PubMed ID: 15837625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
